NCT03425708

Effect of Hyperuricaemia on Chronic Renal Disease

Study on the Effect of Hyperuricaemia on Chronic Renal Disease and Intervention

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 400 (estimated)
• Sponsor: The Affiliated Hospital of Xuzhou Medical University · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

To investigate the Effect of Hyperuricaemia on Chronic Renal Disease and Intervention

Detailed description

This study aims to explore the best effective dose and adverse reaction of febuxostat in lowering serum uric acid to low level in patients with Chronic Renal Disease at different stages. To elucidate that low levels of serum uric acid can delay the progression of renal damage. Promote the application of anti uric acid drugs in the treatment of chronic renal failure and delay the progress of CKD in patients

Conditions

• Hyperuricemia
• Chronic Renal Disease

Interventions

Type	Name	Description
DRUG	20mg Febuxostat	Participants take 20mg febuxostat pill once a day for at least six months.
DRUG	40mg Febuxostat	Participants take 40mg febuxostat pill once a day for at least six months.

Timeline

• Start date: 2017-01-01
• Primary completion: 2018-12-31
• Completion: 2018-12-31
• First posted: 2018-02-07
• Last updated: 2018-02-07

Locations

1 site across 1 country: China